First Houston post-coronavirus clinic part of new UTHealth COVID-19 Center of Excellence
Bringing together expertise and access to the best clinical care, research trials, discovery science, and public health knowledge, The University of Texas Health Science Center at Houston (UTHealth) has established the UTHealth COVID-19 Center of Excellence. The center includes the first post-COVID-19…
Thomas receives COVID-19 research grant
Tina Thomas, MD, a fourth-year psychiatry resident, has received a one-year, $14,990 grant from the American Psychiatric Association Foundation (APA) to explore the impact of COVID-19 in relation to psychiatry. Her project was chosen from a number of grant proposals…
McGovern students create COVID-19 digest
McGovern Medical Students from the Infectious Disease Interest Group have created the “Weekly Digest of COVID-19 Guidelines,” an electronic newsletter to help health care professionals and students at UTHealth stay abreast of the latest information regarding best practices in COVID-19…
Grant awarded for suicide prevention
Through a collaborative effort between UT Physicians and the Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, the university has been awarded a COVID-19 Emergency Response for Suicide grant. Suicide and domestic violence This grant, funded through the Substance…
Team is first in Texas to join NIH-sponsored study investigating efficacy of convalescent plasma for COVID-19
Using a multimillion-dollar grant from the National Institutes of Health, physician-scientists McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth) will investigate whether convalescent plasma infusions can prevent the progression of COVID-19 in one of…
McGovern residents volunteer for COVID-19 front lines
When a crisis occurs, you can almost bet on the health care industry to respond without hesitation to provide support for those in need. Facing the same worries about the COVID-19 pandemic as the rest of the population, medical professionals…
McGovern researchers partner for budding COVID-19 treatment
The Departments of Anesthesiology and Emergency Medicine at McGovern Medical School have been approved for a phase-2 clinical trial to study the effects of a drug to potentially treat COVID-19 patients. The clinical trial is a collaboration with Akebia Therapeutics…
COVID-19 patient at LBJ Hospital recovers after convalescent plasma transfusion
More than a month after her battle with COVID-19, Kony Chacon enjoys spending time with newborn daughter and shows no ill effects from the virus that jeopardized her life and that of her unborn child. She credits a century-old treatment…
Sharrief named to citywide COVID-19 response team
Anjail Sharrief, MD, MPH, associate professor of neurology and director of stroke prevention for the Institute of Stroke and Cerebrovascular Disease, recently was appointed to a citywide COVID-19 response task force. Established by Houston Mayor Sylvester Turner, the Health Equity…
UTHealth joins trial of arthritis drug’s effect on COVID-19-induced cytokine storm
A drug is being studied for its effectiveness in treating a type of severe immune overreaction seen in patients with COVID-19-induced pneumonia by researchers McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth). The clinical…